Marksans Pharma up 3% as arm secures marketing authorisation for Baclofen
The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing ...
Marksans Pharma gains after arm gets nod for Baclofen tablets from UK MHRA
Marksans Pharma advanced 2.61% to Rs 208.15 after the company's wholly owned subsidiary in the UK, Relonchem, has received marketing authorization for Baclofen Tablets from the UK Medicines and ...